Loading...
Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients
Steady state bone marrow (BM) is the preferred hematopoietic stem cell (HSC) source for gene therapy in sickle cell disease (SCD) due to the recognized risk of vaso-occlusive crisis during granulocyte colony–stimulating factor mobilization. We previously established clinically relevant HSC gene tran...
Na minha lista:
| Udgivet i: | Hum Gene Ther Clin Dev |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5695729/ https://ncbi.nlm.nih.gov/pubmed/28447889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/humc.2017.029 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|